Recursion Pharmaceuticals

recursionpharma.com

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease. Recursion applies causative perturbations to human cells to generate disease models and associated biological image data. Recursion’s rich, relatable database of more than a petabyte of biological images generated in-house on the company’s robotics platform enables advanced machine learning approaches to reveal drug candidates, mechanisms of action, and potential toxicity, with the eventual goal of decoding biology and advancing new therapeutics to radically improve lives. Recursion is headquartered in Salt Lake City.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

WEBINAR HOSTED BY XTALKS TO COVER ACTIONS PHARMACEUTICAL COMMERCIAL TEAMS CAN TAKE TO STAY ON TRACK WITH 2020 GOALS

Xtalks | July 08, 2020

news image

COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in...

Read More

Pharma Tech

N-LOREM FOUNDATION PARTNERS WITH ALNYLAM TO EXPAND TECHNOLOGY ACCESS TO RNAI THERAPEUTICS FOR PATIENTS WITH NANO-RARE DISEASES

n-Lorem a nonprofit Foundation | January 20, 2022

news image

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide medicines to nano-rare disease patients for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. “Discovering, developing and providing individualized medicines for nano-rare patients is a monumental task. At n-Lorem, using ASO technology, we take advantage of three decades of experience, unparalleled quality control and integrated safety databases...

Read More

Pharmacy Market

CASCADE CHEMISTRY INITIATES $14 MILLION EXPANSION OF CGMP PHARMACEUTICAL MANUFACTURING CAPACITY

Cascade Chemistry | February 19, 2021

news image

Cascade Chemistry, a main pharmaceutical contract development and manufacturing organization, today declared inception of development of new offices intended to expand the organization's ability to manufacture APIs (dynamic pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures). The new offices, expected to be operational in the main quarter of 2022, will eventually expand the organization's floor space just about three-overl...

Read More

Business Insights

BD COMPLETES ACQUISITION OF PARATA SYSTEMS

BD | July 19, 2022

news image

BD announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care pharmacies. As a combined company, BD is positioned to offer a comprehensive set of technologies to the $600 million pharmacy automati...

Read More
news image

WEBINAR HOSTED BY XTALKS TO COVER ACTIONS PHARMACEUTICAL COMMERCIAL TEAMS CAN TAKE TO STAY ON TRACK WITH 2020 GOALS

Xtalks | July 08, 2020

COVID-19 swiftly changed the healthcare landscape around the world. There has been no rulebook for pharmaceutical commercialization during COVID-19. Pharmaceutical commercialization teams have had to quickly adapt to meet customer, community and business needs. Remote customer engagement and increased patient support services were the answer in the short term for pharmaceutical commercialization amid COVID-19. Longer term, teams will need to adapt brand strategy and executional approaches for in...

Read More
news image

Pharma Tech

N-LOREM FOUNDATION PARTNERS WITH ALNYLAM TO EXPAND TECHNOLOGY ACCESS TO RNAI THERAPEUTICS FOR PATIENTS WITH NANO-RARE DISEASES

n-Lorem a nonprofit Foundation | January 20, 2022

n-Lorem, a nonprofit Foundation, discovering and providing experimental antisense oligonucleotide medicines to nano-rare disease patients for free, for life, today announced a new partnership with Alnylam Pharmaceuticals Inc. “Discovering, developing and providing individualized medicines for nano-rare patients is a monumental task. At n-Lorem, using ASO technology, we take advantage of three decades of experience, unparalleled quality control and integrated safety databases...

Read More
news image

Pharmacy Market

CASCADE CHEMISTRY INITIATES $14 MILLION EXPANSION OF CGMP PHARMACEUTICAL MANUFACTURING CAPACITY

Cascade Chemistry | February 19, 2021

Cascade Chemistry, a main pharmaceutical contract development and manufacturing organization, today declared inception of development of new offices intended to expand the organization's ability to manufacture APIs (dynamic pharmaceutical ingredients) under cGMP (current Good Manufacturing Practices standards and procedures). The new offices, expected to be operational in the main quarter of 2022, will eventually expand the organization's floor space just about three-overl...

Read More
news image

Business Insights

BD COMPLETES ACQUISITION OF PARATA SYSTEMS

BD | July 19, 2022

BD announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce costs, enhance patient safety and improve the patient experience for retail, hospital and long-term care pharmacies. As a combined company, BD is positioned to offer a comprehensive set of technologies to the $600 million pharmacy automati...

Read More